News from NYU Langone Health
Indoors Air Systems Crucial to Curbing Spread of Viruses, Aerosol Researchers Say
CBS News – October 29
-Jonathan D. LaPook, MD, the Mebane Professor of Gastroenterology, Department of Medicine, Division of Gastroenterology and Hepatology, professor, Department of Population Health
Anger Can Motivate People to Achieve Their Goals, New Study Suggests: ‘Sharpened Focus’
FOX News – October 31
-Yamalis Diaz, PhD, clinical assistant professor, Department of Child and Adolescent Psychiatry
NYU Langone Acquires Pediatric Urology Group, Integrating Treatment Teamwork
Brooklyn Eagle – November 2
-Jordan S. Gitlin, MD, adjunct associate professor, Departments of Pediatrics, and Urology, chief, Division of Pediatric Urology, NYU Grossman Long Island School of Medicine
The Best of the Best-in-State Hospitals, per Newsweek
Becker’s Hospital Review – November 1
-NYU Langone Health
146 Hospitals, Systems Ranked by Nurse Support
Becker’s Hospital Review – November 1
-NYU Langone Health
Dr. Weber on Survival Outcomes with mRNA-4157 Plus Pembrolizumab in High-Risk Melanoma
OncLive – November 1
-Jeffrey S. Weber, MD, PhD, the Laura and Isaac Perlmutter Professor of Oncology, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center
Celiac Disease and Higher Risk of Women’s Health Disorders
WebMD – November 1
-Shannon Chang, MD, associate professor, Department of Medicine, Division of Gastroenterology and Hepatology, Inflammatory Bowel Disease Center
First Mice Engineered to Survive COVID-19 like Young, Healthy Humans
ScienMag – November 1
-Jef D. Boeke, PhD, the Sol and Judith Bergstein Director, Institute of System Genetics, professor, Department of Biochemistry and Molecular Pharmacology
Scientists Engineer First Mice to Tolerate COVID-19 like Young Humans
Interesting Engineering – November 1
-Jef D. Boeke, PhD, the Sol and Judith Bergstein Director, Institute of System Genetics, professor, Department of Biochemistry and Molecular Pharmacology
Researchers Genetically Engineer First Mice That Get Human-Like Version of COVID-19—Here’s What Happened
Tech Times – November 2
-Jef D. Boeke, PhD, the Sol and Judith Bergstein Director, Institute of System Genetics, professor, Department of Biochemistry and Molecular Pharmacology
Review Finds no CV or VTE Risk Signal with Use of JAK Inhibitors for Skin Indications
MDedge Dermatology – November 1
-Michael S. Garshick, MD, assistant professor, Department of Medicine, the Leon H. Charney Division of Cardiology, and the Ronald O. Perelman Department of Dermatology
Study Finds No Signals for CV, VTE Risk with JAK Inhibitors for Skin Diseases
(Free log-in required.)
Medscape – November 1
-Michael S. Garshick, MD, assistant professor, Department of Medicine, the Leon H. Charney Division of Cardiology, and the Ronald O. Perelman Department of Dermatology
How SARS-CoV-2 Contributes to Heart Attacks and Strokes
Cancer Health – November 1
-Chiara Giannarelli, MD, PhD, associate professor, Department of Medicine, the Leon H. Charney Division of Cardiology, and Department of Pathology
News from NYU Langone Hospital—Long Island
Daylight Savings Time Could Trigger Migraines
FOX 5 New York – November 2
-Shae Datta, MD, clinical assistant professor, Department of Neurology, NYU Langone Hospital—Long Island, Concussion Center
